BRIAN QUARTON: Open Payments
NPI 1417951401 · GILLESPIE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$861 in 44 payments from 12 companies in 2025. Trend: 2023 $825 · 2024 $681 · 2025 $861
Food & beverage: $861
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $170 |
| Novo Nordisk Inc | 9 | $138 |
| PFIZER INC. | 6 | $113 |
| ABBVIE INC. | 5 | $104 |
| Janssen Pharmaceuticals, Inc | 2 | $63 |
| Lilly USA, LLC | 3 | $61 |
| Amgen Inc. | 3 | $58 |
| Viatris Specialty LLC | 3 | $50 |
| Seqirus USA Inc | 1 | $42 |
| Braeburn Inc. | 1 | $26 |
Products named: Ozempic, QULIPTA, FARXIGA, SPRAVATO, NURTEC ODT, MOUNJARO, AIRSUPRA, YUPELRI.
Industry payments across IL — which companies pay providers there.
